Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,692
Total Claims
$3.1M
Drug Cost
1,244
Beneficiaries
$2,479
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
-52%
Cost per patient vs peers
$2,479 vs $5,138 avg
-43%
Brand preference vs peers
34.9% vs 61.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.3%
Opioid Rate
36
Opioid Claims
$306
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,406 claims · $2.9M
Generic: 8,235 claims · $197K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | 1,502 | $1.1M |
| Nintedanib Esylate | 41 | $456K |
| Budesonide/Glycopyr/Formoterol | 330 | $226K |
| Umeclidinium Brm/Vilanterol Tr | 395 | $206K |
| Budesonide/Formoterol Fumarate | 392 | $180K |
| Fluticasone/Vilanterol | 327 | $153K |
| Dupilumab | 24 | $86K |
| Dupilumab | 18 | $68K |
| Tiotropium Br/Olodaterol Hcl | 90 | $48K |
| Tiotropium Bromide | 45 | $33K |
| Sitagliptin Phosphate | 26 | $28K |
| Apixaban | 41 | $25K |
| Albuterol Sulfate | 848 | $25K |
| Sucralfate | 260 | $22K |
| Fluticasone Propion/Salmeterol | 29 | $18K |
Prescribing Profile
Patient Profile
73
Avg Age
60%
Female
2.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About